PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics, Ltd. (NASDAQ:ROSG) a leading developer of microRNA-based molecular diagnostics, announced that Kenneth A. Berlin, president and chief executive officer, will be participating in a panel discussion entitled, “Issues and Opportunities in Molecular Diagnostics,” at 11:00 a.m. and will be presenting a corporate update at 1:10 p.m. at Leerink Swan’s Life Science Tools and Diagnostics Roundtable Conference being held on Thursday, August 5, 2010 at The Roosevelt Hotel in New York City.
